Increased Prevalence of Human Papillomavirus in Hairs Plucked from Patients with Psoriasis Treated with Psoralen-UV-A

Archives of Dermatology

Volumn 140, Issue 3, 2004, Pages 317-324

  Wolf, Peter ^a   Seidl, Hannes ^a   Bäck, Barbara ^a   Binder, Barbara ^a   Höfler, Gerald ^a   Quehenberger, Franz ^a   Hoffmann, Christine ^a   Kerl, Helmut ^a   Stark, Sabine ^b   Pfister, Herbert J ^b   Fuchs, Pawel G ^b  

^a UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PSORALEN;

ADULT; AGED; ARTICLE; DRUG EFFECT; FEMALE; HUMAN; IONIZING RADIATION; MAJOR CLINICAL STUDY; MALE; ONCOGENE H RAS; PAPILLOMA VIRUS; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; PUVA; RADIATION EXPOSURE; SAMPLING; SCREENING; SKIN CANCER; ULTRAVIOLET A RADIATION; VIRUS EXPRESSION; VIRUS INFECTION; VIRUS REPLICATION; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; AUSTRIA; CASE-CONTROL STUDIES; DNA, VIRAL; FEMALE; FICUSIN; HAIR; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PHOTOSENSITIZING AGENTS; PREVALENCE; PSORIASIS; PUVA THERAPY;

EID: 12144289676     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.140.3.317     Document Type: Article

References (47)

1. Stern RS, Liebman EJ, Väkevä L. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer: PUVA Follow-up Study. J Natl Cancer Inst. 1998;90:1278-1284.
2. Nataraj AJ, Wolf P, Cerroni L, Ananthaswamy HN. p53 mutations in squamous cell carcinomas from psoriasis patients treated with psoralen+UVA (PUVA). J Invest Dermatol. 1997;109:238-243.
3. Wang XM, McNiff JM, Klump V, Asgari M, Gasparro FP. An unexpected spectrum of p53 mutations from squamous cell carcinomas in psoriasis patients treated with PUVA. Photochem Photobiol. 1997;66:294-299.
4. Seidl H, Kreimer-Erlacher H, Bäck B, et al. Ultraviolet exposure as the main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis. J Invest Dermatol. 2001;117:365-370.
5. Kreimer-Erlacher H, Seidl H, Bäck B, Cerroni L, Kerl H, Wolf P. High frequency of ultraviolet mutations at the INK4a-ARF locus in squamous cell carcinomas from psoralen-plus-ultraviolet-A-treated psoriasis patients. J Invest Dermatol. 2003;120:676-682.
6. Kreimer-Erlacher H, Seidl H, Bäck B, Kerl H, Wolf P. High mutation frequency at Ha-ras exons 1-4 in squamous cell carcinomas from PUVA-treated psoriasis patients. Photochem Photobiol. 2001;74:323-330.
7. Strauss GH, Bridges BA, Greaves M, Hall-Smith P, Price M, Vella-Briffa D. Inhibition of delayed hypersensitivity reaction in skin (DNCB test) by 8-methoxypsoralen photochemotherapy: possible basis for pseudo-promoting action in skin carcinogenesis? Lancet. 1980;2:556-559.
8. Kripke ML, Morison WL, Parrish JA. Systemic suppression of contact hypersensitivity in mice by psoralen plus UVA radiation (PUVA). J Invest Dermatol. 1983;81:87-92.
9. Maier H, Schemper M, Ortel B, Binder M, Tanew A, Hönigsmann H. Skin tumors in photochemotherapy for psoriasis: a single-center follow-up of 496 patients. Dermatology. 1996;193:185-191.
10. Bouwes Bavinck JN, Feltkarmp M, Struijk L, ter Scheggett J. Human papillomavirus infection and skin cancer risk in organ transplant recipients. J Investig Dermatol Symp Proc. 2001;6:207-211.
11. Jenson AB, Geyer S, Sundberg JP, Ghim S. Human papillomavirus and skin cancer. J Investig Dermatol Symp Proc. 2001;6:203-206.
12. Majewski S, Jablonska S. Do epidermodysplasia verruciformis human papillomaviruses contribute to malignant and benign epidermal proliferations? Arch Dermatol. 2002;138:649-654.
13. Harwood CA, Proby CM. Human papillomaviruses and non-melanoma skin cancer. Curr Opin Infect Dis. 2002;15:101-114.
14. Jackson S, Ghali L, Harwood C, Storey A. Reduced apoptotic levels in squamous but not basal cell carcinomas correlates with detection of cutaneous human papillomavirus. Br J Cancer. 2002;87:319-323.
15. Jackson S, Storey A. E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage. Oncogene. 2000;19:592-598.
16. Boxman IL, Russell A, Mulder LH, Bavinck JN, Schegget JT, Green A, Nambour Skin Cancer Prevention Study Group. Case-control study in a subtropical Australian population to assess the relation between non-melanoma skin cancer and epidermodysplasia verruciformis human papillomavirus DNA in plucked eyebrow hairs. Int J Cancer. 2000;86:118-121.
17. Orth G. Epidermodysplasia verruciformis. In: Salzman NP, Howley PM, eds. The Papovaviridae: The Papillomaviruses. New York, NY: Plenum Press; 1987:199-243.
18. Tieben LM, Berkhout RJ, Smits HL, et al. Detection of epidermodysplasia verruciformis-like human papillomavirus types in malignant and premalignant skin lesions of renal transplant recipients. Br J Dermatol. 1994;131:226-230.
19. Berkhout RJ, Tieben LM, Smits HL, Bavinck JN, Vermeer BJ, ter Schegget J. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol. 1995;33:690-695.
20. Höpfl R, Bens G, Wieland U, et al. Human papillomavirus DNA in non-melanoma skin cancers of a renal transplant recipient: detection of a new sequence related to epidermodysplasia verruciformis associated types. J Invest Dermatol. 1997;108:53-56.
21. Antonsson A, Forslund O, Ekberg A, Sterner G, Hanson B. The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J Virol. 2000;74:11636-11641.
22. Ffister H, Schegget JT. Role of HPV in cutaneous premalignant and malignant tumors. Clin Dermatol. 1997;15:335-347.
23. Harwood CA, Surentheran T, McGregor JM, et al. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol. 2000;61:289-297.
24. Biliris KA, Koumantakis E, Dokianakis DN, Sourvinos G, Spandidos DA. Human papillomavirus infection of non-melanoma skin cancers in immunocompetent hosts. Cancer Lett. 2000;161:83-88.
25. Burmer GC, True LD, Krieger JN. Squamous cell carcinoma of the scrotum associated with human papillomaviruses. J Urol. 1993;149:374-377.
26. Bayle-Lebey P, Labadie F, Basset-Seguin N, Bazex J. Carcinomes cutanés et papillomavirus 5: révélation lors d'une photochimiothérapie UVA prolongée. Ann Dermatol Venereol. 1994;121:496-498.
27. Weinstock MA, Coulter S, Bates J, Bogaars HA, Larson PL, Burmer GC. Human papillomavirus and widespread cutaneous carcinoma after PUVA photochemotherapy. Arch Dermatol. 1995;131:701-704.
28. Rübben A, Baron JM, Grussendorf-Conen EI. Demonstration of human papillomavirus type 16-related DNA and absence of detectable p53 gene mutations in widespread cutaneous squamous cell carcinomas after oral psoralen with UV-A treatment. Arch Dermatol. 1996;132:1257-1259.
29. Harwood CA, Spink PJ, Surentheran T, et al. Detection of human papillomavirus DNA in PUVA-associated non-melanoma skin cancers. J Invest Dermatol. 1998;111:123-127.
30. Zumtobel U, Schwarze HP, Favre M, Taieb A, Delaunay M. Widespread cutaneous carcinomas associated with human papillomaviruses 5, 14 and 20 after introduction of methotrexate in two long-term PUVA-treated patients. Dermatology. 2001;202:127-130.
31. Favre M, Orth G, Majewski S, Jablonska S. PUVA therapy and human papillomavirus type 5 detection in psoriasis [letter]. J Invest Dermatol. 1998;111:913.
32. Weissenborn SJ, Höpfl R, Weber F, Smola H, Pfister HJ, Fuchs PG. High prevalence of a variety of epidermodysplasia verruciformis-associated human papillomaviruses in psoriatic skin of patients treated or not treated with PUVA. J Invest Dermatol. 1999;113:122-126.
33. Boxman IL, Berkhout RJ, Mulder LH, et al. Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol. 1997;108:712-715.
34. Meyer T, Arndt R, Christophers E, Nindl I, Stockfleth E. Importance of human papillomaviruses for the development of skin cancer. Cancer Detect Prev. 2001;25:533-547.
35. de Roda Husman AM, Snijders PJF, Stel HV, Van den Brule AJC, Meijer CJLM, Walboomers JMM. Processing of long-stored archival cervical smears for human papillomavirus detection by polymerase chain reaction. Br J Cancer. 1995;72:412-417.
36. Wieland U, Ritzkowsky A, Stoltidis M, et al. Papillomavirus DNA in basal cell carcinomas of immunocompetent patients: an accidental association? J Invest Dermatol. 2000;115:124-128.
37. Kwok S. Procedure to minimize PCR-product carry-over. In: Innis MA, Gelfand DH, Sninski JJ, White TJ, eds. PCR Protocols-A Guide to Methods and Applications. San Diego, Calif: Academic Press; 1990:142-145.
38. Altschul SF, Madden TL, Schäffer AA, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997;25:3389-3402.
39. De Villiers EM. Taxonomic classification of papillomaviruses. Papillomavirus Rep. 2001;12:57-63.
40. Myers G, Sverdrup F, Baker C, McBride A, Münger K, Bernard HU, eds. Human Papillomaviruses. Los Alamos, NM: Los Alamos National Laboratory; 1997.
41. Boxman IL, Mulder LH, Russell A, Bouwes Bavinck JN, Green A, Ter Schegget J. Human papillomavirus type 5 is commonly present in immunosuppressed and immunocompetent individuals. Br J Dermatol. 1999;141:246-249.
42. Boxman IL, Hogewoning A, Mulder LH, Bouwes-Bavinck JN, ter Schegget J. Detection of human papillomavirus types 6 and 11 in pubic and perianal hair from patients with genital warts. J Clin Microbiol. 1999;37:2270-2273.
43. Favre M, Majewski S, Noszczyk B, Maienfisch F, Pura A, Orth G. Antibodies to human papillomavirus 5 are generated in epidermal repair processes. J Invest Dermatol. 2000;114:403-407.
44. Purdie KJ, Pennington J, Proby CM, et al. The promoter of a novel human papillomavirus (HPV77) associated with skin cancer displays UV responsiveness, which is mediated through a consensus p53 binding sequence. EMBO J. 1999;18:5359-5369.
45. De Villiers EM, Ruhland A, Sekaric P. Human papillomaviruses in non-melanoma skin cancer. Semin Cancer Biol. 1999;9:413-422.
46. Scheurlen W, Gissmann L, Gross G, zur Hausen H. Molecular cloning of two new HPV types (HPV 37 and HPV 38) from a keratoacanthoma and a malignant melanoma. Int J Cancer. 1986;37:505-510.
47. Favre M, Orth G, Majewski S, Baloul S, Pura A, Jablonska S. Psoriasis: a possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis. J Invest Dermatol. 1998;110:311-317.